{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-269359","form_type":"8-K/A","ticker":"MIRM","cik":"0001759425","company_name":"Mirum Pharmaceuticals, Inc.","filed_at":"2023-11-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.336515+00:00","generated_at":"2026-06-09T00:42:39.873161+00:00","sec_items":["9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Mirum acquires Bile Acid Business from Travere for up to $445M; H1 2023 revenue $53.6M, net income $13.6M","bullets":["Acquired Chenodal and Cholbam assets for up to $445M ($210M upfront + up to $235M milestone payments).","PIPE of 8M shares at $26.25 raised ~$202.2M net proceeds to fund acquisition.","Acquired business had net product sales of $53.6M and net income of $13.6M for H1 2023 (unaudited).","Pro forma combined financial statements filed; acquisition closed August 31, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-269359","json":"https://secwatch.observer/filing/0001193125-23-269359.json","markdown":"https://secwatch.observer/filing/0001193125-23-269359.md","text":"https://secwatch.observer/filing/0001193125-23-269359.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1759425/000119312523269359/0001193125-23-269359-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1759425/000119312523269359/d323300d8ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T00:42:39.873161+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}